| Feature | Specification |
|---|---|
| Application |
cAMP Drug Discovery & Development |
| G-Alpha Natural Receptor | Gs |
| Validation |
cAMP Downstream Phosphorylation |
Melanocortin MC3 cAMPZen cells are validated frozen cells designed for high-throughput screening to identify drug candidates targeting the human Melanocortin MC3 receptor expressed in CHO-K1 host cells. The cAMPZen technology enables researchers to easily detect changes in cAMP levels as a direct indicator of receptor activation, making it valuable for tool for drug discovery. Each vial contains 2.5 million frozen cells validated for cAMP testing, providing a consistent and ready-to-use supply that streamlines workflows and accelerates drug discovery. The frozen format ensures reliable performance while maintaining cell viability. Please note that these cells are authorized for single-use only, and transfer, re-use, or propagation is not permitted under the product terms and conditions.
| Application |
cAMP
Drug Discovery & Development
|
|---|---|
| Brand |
cAMPZen
|
| G-Alpha Natural Receptor |
Gs
|
| Host Cell Line |
CHO-K1
|
| Host Species |
Human
|
| One Unit Contains |
1 vial(s)
|
| Product Group |
Cell Line
|
| Receptor |
Melanocortin
|
| Second Messenger Release |
cAMP
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target Class |
GPCR
|
| Therapeutic Area |
Inflammation
Metabolic
Pain
|
| Unit Size |
2.5 million cells
|
| Validation |
cAMP
Downstream Phosphorylation
|
Are you looking for resources, click on the resource type to explore further.
Discover a comprehensive collection of GPCR cell lines, membrane preparations, and complementary radioligands designed to drive...
We are here to answer your questions.